Mitazalimab (Anti-TNFRSF5 / CD40)
Mitazalimab (Anti-TNFRSF5 / CD40) a human agonist IgG1 antibody targeting CD40. It enhances the anti-tumor efficacy of a model cancer vaccine. MW :143.44 KD.
| Trivial name | ADC-1013; JNJ-64457107 |
| Catalog Number | A3088 |
| CAS# | 2055640-86-1 |
| Size | 1mg |